Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Cellular Immunology|January 14, 2018
Role of the IL-33/ST2L axis in colorectal cancer progressionMiho Akimoto, Keizo TakenagaCancer Science|July 25, 2007
Therapeutic strategy using phenotypic modulation of cancer cells by differentiation-inducing agentsYoshio Honma, Miho AkimotoScientific Reports|February 4, 2021
Obesity reduces the anticancer effect of AdipoRon against orthotopic pancreatic cancer in diet-induced obese miceKeizo Takenaga, Miho Akimoto, Nobuko Koshikawa, et al.Plos One|April 28, 2020
Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer modelKeizo Takenaga, Miho Akimoto, Nobuko Koshikawa, et al.Oncotarget|May 6, 2017
HIF-2α dictates the susceptibility of pancreatic cancer cells to TRAIL by regulating survivin expressionNanae Harashima, Keizo Takenaga, Miho Akimoto, et al.Nature Communications|November 25, 2016
Soluble IL-33 receptor sST2 inhibits colorectal cancer malignant growth by modifying the tumour microenvironmentMiho Akimoto, Riruke Maruyama, Hiroyuki Takamaru, et al.Plos One|May 12, 2015
Anticancer Effect of Ginger Extract against Pancreatic Cancer Cells Mainly through Reactive Oxygen Species-Mediated Autotic Cell DeathMiho Akimoto, Mari Iizuka, Rie Kanematsu, et al.Cell Death & Disease|July 25, 2018
Antidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1/ERK-dependent necroptosisMiho Akimoto, Riruke Maruyama, Yasunari Kawabata, et al.Scientific Reports|November 16, 2017
Association of predicted pathogenic mutations in mitochondrial ND genes with distant metastasis in NSCLC and colon cancerNobuko Koshikawa, Miho Akimoto, Jun-Ichi Hayashi, et al.Tumori|June 11, 2013
Antitumor effect of Japanese apricot extract (MK615) on human cancer cells in vitro and in vivo through a reactive oxygen species-dependent mechanismMiho Hattori, Koshi Kawakami, Miho Akimoto, et al.Pageof 3